No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LXEO Lexeo Therapeutics
- 13.560
- +0.420+3.20%
Close May 13 16:00 ET
446.74MMarket Cap-6432P/E (TTM)
13.580High12.980Low62.20KVolume13.130Open13.140Pre Close826.07KTurnover0.32%Turnover RatioLossP/E (Static)32.95MShares22.33052wk High2.44P/B263.01MFloat Cap9.00052wk Low--Dividend TTM19.40MShs Float22.330Historical High--Div YieldTTM4.57%Amplitude9.000Historical Low13.281Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Lexeo Therapeutics | 10-Q: Quarterly report
Lexeo Therapeutics 1Q Research and Developement Expenses $15.7M >LXEO
Lexeo Therapeutics 1Q Research and Developement Expenses $15.7M >LXEO
Lexeo Therapeutics 1Q Loss/Shr 77c >LXEO
Lexeo Therapeutics 1Q Loss/Shr 77c >LXEO
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and
Buy Rating Affirmed for Lexeo Therapeutics Amid Strategic Cornell Collaboration and Promising Therapy Advancements
Bernard Davitian to Exit Board of Lexeo Therapeutics
Lexeo Therapeutics, Inc. (LXEO) has issued an update.
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg